Hospital Doctor Balmis participates in international trial against rare blood cancer
The Alicante centre joins a global clinical study to improve treatment of myelofibrosis, a rare cancer affecting the bone marrow.
Hospital General Universitario Doctor Balmis de Alicante is taking part in an international clinical trial aimed at advancing the treatment of myelofibrosis, a rare form of haematological cancer that damages the bone marrow.
This global research seeks to develop new therapies and management protocols for patients with this uncommon disease, improving their quality of life and prognosis.
The Alicante centre’s participation reinforces its position as a reference in oncological research and enables local patients to access innovative treatments within a controlled research framework.
Myelofibrosis affects the bone marrow’s ability to produce normal blood cells, causing serious complications that require ongoing specialised care.
Source: informacion.es
Related news
- GeneralAigües d'Elx launches plan for San Antón ravine with €33 million investment
The joint-venture company will allocate €33 million by 2030 for sanitation works and a masterplan to prevent flooding on the Santa Pola road using wetlands.
- GeneralTSJCV acquits former Torrevieja councillor Carmen Gómez over cleaning emergency plan
The High Court of Justice overturns the administrative malfeasance conviction against former PP councillor Carmen Gómez Candel related to the cleaning emergency plan.